Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Functional precision oncology using patient-derived assays: bridging genotype and phenotype
Allard W. J. van Renterghem, Joris van de Haar, Emile E. Voest
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 5, pp. 305-317
Closed Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Precision treatment in advanced hepatocellular carcinoma
Xupeng Yang, Chen Yang, Shu Zhang, et al.
Cancer Cell (2024) Vol. 42, Iss. 2, pp. 180-197
Open Access | Times Cited: 118
Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment
Roel Polak, Elisa T. Zhang, Calvin J. Kuo
Nature reviews. Cancer (2024) Vol. 24, Iss. 8, pp. 523-539
Closed Access | Times Cited: 44
Pancreatic cancer environment: from patient-derived models to single-cell omics
Ao Gu, Jiatong Li, Shimei Qiu, et al.
Molecular Omics (2024) Vol. 20, Iss. 4, pp. 220-233
Closed Access | Times Cited: 24
Feasibility of functional precision medicine for guiding treatment of relapsed or refractory pediatric cancers
Arlet Acanda de la Rocha, Noah Berlow, Maggie Fader, et al.
Nature Medicine (2024) Vol. 30, Iss. 4, pp. 990-1000
Open Access | Times Cited: 21
Novel clinical trial designs emerging from the molecular reclassification of cancer
Mina Nikanjam, Shumei Kato, Teresa Allen, et al.
CA A Cancer Journal for Clinicians (2025)
Open Access | Times Cited: 3
Organoids for Functional Precision Medicine in Advanced Pancreatic Cancer
Alice Boilève, Jérôme Cartry, Negaar Goudarzi, et al.
Gastroenterology (2024) Vol. 167, Iss. 5, pp. 961-976.e13
Open Access | Times Cited: 11
GDF15 induces chemoresistance to oxaliplatin by forming a reciprocal feedback loop with Nrf2 to maintain redox homeostasis in colorectal cancer
Haiping Lin, Yang Luo, Tingyue Gong, et al.
Cellular Oncology (2024) Vol. 47, Iss. 4, pp. 1149-1165
Closed Access | Times Cited: 10
Moving toward precision medicine to predict drug sensitivity in patients with metastatic breast cancer
Michele Bottosso, F. Mosele, Stefan Michiels, et al.
ESMO Open (2024) Vol. 9, Iss. 3, pp. 102247-102247
Open Access | Times Cited: 9
Tumour organoids and assembloids: Patient‐derived cancer avatars for immunotherapy
Jie Mei, Xingjian Liu, Huixiang Tian, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 4
Open Access | Times Cited: 8
Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition
Florencia P. Madorsky Rowdo, Rachel Martini, Sarah Ackermann, et al.
Cancer Research (2025) Vol. 85, Iss. 3, pp. 551-566
Open Access | Times Cited: 1
Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer
Jérôme Cartry, Sabrina Bedja, Alice Boilève, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 14
Next‐Generation Preclinical Functional Testing Models in Cancer Precision Medicine: CTC‐Derived Organoids
Lanxiang Huang, Yaqi Xu, Na Wang, et al.
Small Methods (2023) Vol. 8, Iss. 1
Closed Access | Times Cited: 14
Breast cancer organoids derived from patients: A platform for tailored drug screening
Yen‐Dun Tony Tzeng, Jui‐Hu Hsiao, Ling‐Ming Tseng, et al.
Biochemical Pharmacology (2023) Vol. 217, pp. 115803-115803
Open Access | Times Cited: 13
Patient‐Derived Microphysiological Systems for Precision Medicine
Jihoon Ko, Jiyoung Song, Nakwon Choi, et al.
Advanced Healthcare Materials (2023) Vol. 13, Iss. 7
Open Access | Times Cited: 13
Therapeutic Peptides, Proteins and their Nanostructures for Drug Delivery and Precision Medicine
Ha Ram Kim, Boghos Taslakjian, Sarah Kim, et al.
ChemBioChem (2024) Vol. 25, Iss. 8
Open Access | Times Cited: 5
Engineering Stimuli‐Responsive Materials for Precision Medicine
Ruixuan Zheng, Yu Chang, Dan Yao, et al.
Small (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Long-term maintenance of patient-specific characteristics in tumoroids from six cancer indications
Colin D. Paul, Chris Yankaskas, Pradip Shahi Thakuri, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
"Harnessing the Power of Organoids for Improved Outcomes in Pancreatic Cancer"
Laxmi Kirola, Saurabh Kedia, Sujata Mohanty
Pancreatology (2025)
Closed Access
OncoFlow: A Multiplexed Microfluidic Platform for Personalized Drug Sensitivity Assessment
Matan Krasner, Efrat Barbiro‐Michaely, Ulrike Bening Abu-Shach, et al.
New Biotechnology (2025)
Open Access
HMGA1 sensitizes esophageal squamous cell carcinoma to mTOR inhibitors through the ETS1-FKBP12 axis
Jin-Rong Guo, Kai-Yue He, Jiali Yuan, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 7, pp. 2640-2657
Open Access | Times Cited: 3
Immune‐related adverse events of antibody‐based biological medicines in cancer therapy
Deepa Rajagopal, Elliot MacLeod, Diana Corogeanu, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 13
Open Access | Times Cited: 3
Cancer-on-a-chip model shows that the adenomatous polyposis coli mutation impairs T cell engagement and killing of cancer spheroids
Valentin Bonnet, Erik Maikranz, Marianne Madec, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 11
Open Access | Times Cited: 2
Vitamin D opposes multilineage cell differentiation induced by Notch inhibition and BMP4 pathway activation in human colon organoids
Pilar Bustamante‐Madrid, Antonio Barbáchano, David Albandea‐Rodríguez, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 2
Zebrafish Avatars: Toward Functional Precision Medicine in Low-Grade Serous Ovarian Cancer
Charlotte Fieuws, Jan Willem Bek, Bram Parton, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1812-1812
Open Access | Times Cited: 2
XENTURION is a population-level multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patients
Simonetta M. Leto, Elena Grassi, Marco Avolio, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top